ME/CFS AUSTRALIA (SA) INC Registered Charity 698 Mailing address: GPO Box 383, Adelaide, South Australia 5001 Office: 266 Port Road, Hindmarsh, South Australia 5007 Ph: (08) 8346 3237 ('834 MECFS') Office Hours: Wednesdays, 10am-3pm Support Line: (Mondays and Thursdays, 10am-3pm) Ph: (08) 8346 3237 SA country callers: Ph: 1300 128 339 (local call)
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
Disclaimer ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives. Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services. |
|
|||||||||||||
National CFIDS Foundation awardWednesday 30 May 2007
The announcement of the award was made by the Foundation in the following press release: The National CFIDS Foundation will present its first “Outstanding Researcher Award” to Yoshitsugi Hokama, Ph.D. Professor of Pathology at the John A. Burns School of Medicine, University of Hawaii at Manoa. From 2002 to 2007, Dr Hokama received financial support from the Foundation’s Research Grant Program, to research the role of chronic phase lipids and ciguatera toxin reactivity in patients with chronic fatigue immune dysfunction syndrome (CFIDS) also known as myalgic encephalomyelitis (ME) by the World Health Organization (WHO). The award is being presented to Dr. Yoshitsugi Hokama by interim acting dean Dr. Gary Ostrander, on behalf of the National CFIDS Foundation in recognition of his “significant scientific contributions exemplary commitment and dedication to the worldwide patient community.” Since the announcement of his discovery at a medical conference in Japan Dr. Hokama had secured an international blood permit so that millions of patients worldwide who suffered with the disease would have access to testing offered by the medical school. The test identified ciguatera toxin reactivity in the blood of over 95% of all those afflicted with CFIDS/ME/CFS. By providing the necessary financial support, the Foundation’s grants enabled Dr. Hokama to receive additional funding for his research from the National Institutes of Health(NIH). May 12th is International Awareness Day for CFIDS/ME/CFS and is observed with various activities around the world. The date was chosen to memorialize the birth date of Florence Nightingale who inspired the founding of the International Red Cross while bedridden and suffering from a neurological condition similar to CFIDS/ME. The award presented to Dr. Hokama to honor his pioneering work is the charity’s first-ever award and was purposefully awarded at this time to coincide with Awareness Day. Like Florence Nightingale, Dr. Hokama has been the inspiration for many due to his dedication and commitment to help others. |
||||||||||||||